Searching News Database: Fosun Pharma
HSMN NewsFeed - 4 Apr 2022
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
HSMN NewsFeed - 24 Apr 2018
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
HSMN NewsFeed - 12 Oct 2007
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)